| Cases (N = 1213) | Controls (N = 1561) | P |
---|---|---|---|
Age (years) M (IQTR) | 60 (53-65) | 61 (54-66) | 0.03 |
Sex (M/F) (N) | 852/361 | 1054/507 | 0.06 |
SBP (mmHg) M (IQTR) | 130 (117-145) | 140 (125-155) | <0.0001 |
DPB (mmHg) M (IQTR) | 80 (72-86) | 82 (77-90) | <0.0001 |
BMI (kg/m2) M (IQTR) | 26 (23-28) | 25.1 (23-27) | <0.0001 |
Lipid lowering therapy N(%) | 59 (4.8) | 55 (3.6) | 0.55 |
Biochemistry M(IQTR) | Â | Â | Â |
T-Chol (mmol/L) | 6.1 (5.4-6.9) | 5.9 (5.2-6.6) | <0.0001 |
LDL-Chol (mmol/L) | 4.2 (3.6-4.8) | 3.9 (3.3-4.6) | <0.0001 |
HDL-Chol (mmol/L) | 1 (0.9-1.3) | 1.2 (1.0-1.5) | <0.0001 |
TG (mmol/L) | 1.7 (1.2-2.4) | 1.3 (0.9-1.8) | <0.0001 |
ApoA1 (g/L) | 1.3 (1.2-1.5) | 1.5 (1.3-1.7) | <0.0001 |
ApoB (g/L) | 1.6 (1.4-1.9) | 1.4 (1.2-1.7) | <0.0001 |
Risk Factors N(%) | Â | Â | Â |
Family History | 400 (32) | 358 (23) | <0.0001 |
Hypertension | 561 (46) | 817 (53) | 0.001 |
Diabetes | 151 (12) | 72 (4.7) | <0.0001 |
Hypercholesterolemia | 514 (42) | 467 (30) | <0.0001 |
Hypertriglyceridemia | 314 (25) | 200 (13) | <0.0001 |
BMI > 30 kg/m2 | 227 (19) | 197 (13) | <0.0001 |
Current Smokers | 580 (48) | 455 (29) | <0.0001 |
Physical Inactivity | 523 (43) | 536 (34) | 0.001 |